APGE
Price
$35.39
Change
-$0.61 (-1.69%)
Updated
Aug 8 closing price
Capitalization
2.06B
23 days until earnings call
MLYS
Price
$13.00
Change
+$0.13 (+1.01%)
Updated
Aug 8 closing price
Capitalization
847.28M
3 days until earnings call
Interact to see
Advertisement

APGE vs MLYS

Header iconAPGE vs MLYS Comparison
Open Charts APGE vs MLYSBanner chart's image
Apogee Therapeutics
Price$35.39
Change-$0.61 (-1.69%)
Volume$622.27K
Capitalization2.06B
Mineralys Therapeutics
Price$13.00
Change+$0.13 (+1.01%)
Volume$505.74K
Capitalization847.28M
APGE vs MLYS Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. MLYS commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and MLYS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2025
Stock price -- (APGE: $35.39 vs. MLYS: $13.00)
Brand notoriety: APGE and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 65% vs. MLYS: 55%
Market capitalization -- APGE: $2.06B vs. MLYS: $847.28M
APGE [@Biotechnology] is valued at $2.06B. MLYS’s [@Biotechnology] market capitalization is $847.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileMLYS’s FA Score has 1 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • MLYS’s FA Score: 1 green, 4 red.
According to our system of comparison, MLYS is a better buy in the long-term than APGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 3 TA indicator(s) are bullish while MLYS’s TA Score has 3 bullish TA indicator(s).

  • APGE’s TA Score: 3 bullish, 7 bearish.
  • MLYS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а -6.25% price change this week, while MLYS (@Biotechnology) price change was -4.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

APGE is expected to report earnings on Sep 01, 2025.

MLYS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.06B) has a higher market cap than MLYS($847M). MLYS YTD gains are higher at: 5.605 vs. APGE (-21.876). MLYS has higher annual earnings (EBITDA): -201.44M vs. APGE (-241.42M). APGE has more cash in the bank: 513M vs. MLYS (343M). APGE (0) and MLYS (0) have equivalent revenues.
APGEMLYSAPGE / MLYS
Capitalization2.06B847M244%
EBITDA-241.42M-201.44M120%
Gain YTD-21.8765.605-390%
P/E RatioN/AN/A-
Revenue00-
Total Cash513M343M150%
Total Debt11.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
APGEMLYS
RSI
ODDS (%)
Bearish Trend 4 days ago
62%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 18 days ago
85%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VNSCX20.680.09
+0.44%
Natixis Vaughan Nelson Select C
TRVHX18.06N/A
N/A
Nuveen Mid Cap Value I
HSMAX11.81N/A
N/A
Hartford Small Cap Value A
OEGIX35.92N/A
N/A
Invesco Discovery Mid Cap Growth R6
NEQIX12.87N/A
N/A
Neuberger Berman U.S. Equity Impact I

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-1.69%
SYRE - APGE
52%
Loosely correlated
-0.52%
CRNX - APGE
50%
Loosely correlated
-3.69%
ERAS - APGE
48%
Loosely correlated
-4.11%
IDYA - APGE
48%
Loosely correlated
+3.08%
IRON - APGE
47%
Loosely correlated
+1.68%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+1.01%
PTGX - MLYS
50%
Loosely correlated
+0.22%
BIESF - MLYS
45%
Loosely correlated
N/A
APGE - MLYS
36%
Loosely correlated
-1.69%
ACLX - MLYS
35%
Loosely correlated
-0.91%
XERS - MLYS
34%
Loosely correlated
+3.64%
More